Location: Chicago, IL
CIK: 0001274403 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 12, 2020
Total Value: $29.72M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RUBIUS THERAPEUTICS INC | 2,618,351 | $15.66M | 52.7% | $16.08 | — | COM | 78116T103 |
| — | CHIASMA INC | 1,196,776 | $6.439M | 21.7% | $3.11 | — | COM | 16706W102 |
| — | SYROS PHARMACEUTICALS INC | 400,000 | $4.264M | 14.3% | $10.38 | — | COM | 87184Q107 |
| KURA | KURA ONCOLOGY INC | 206,307 | $3.363M | 11.3% | $13.25 | +8.9% | COM | 50127T109 |